HPV Testing for Cervical Cancer

Recruiting in Palo Alto (17 mi)

Age: 18+

Sex: Female

Travel: May Be Covered

Time Reimbursement: Varies

Trial Phase: Academic

Waitlist Available

Sponsor: University of Rochester

No Placebo Group

Trial Summary

What is the purpose of this trial?Cervical cancer screening in the Emergency Department

Eligibility Criteria

This trial is for individuals who visit the emergency department and may be at risk of cervical cancer or human papillomavirus (HPV) infection. Specific eligibility criteria are not provided, but typically participants would need to meet certain health conditions.

Inclusion Criteria

I am a cisgender woman or a transgender/non-binary person with a cervix.

I can make my own decisions about joining a study.

I am between 25 and 65 years old.

Exclusion Criteria

I have had a hysterectomy that included the removal of my cervix.

I have been diagnosed with HIV.

Non-English speaking

Participant Groups

The study is testing the feasibility and effectiveness of conducting HPV testing as a method for cervical cancer screening in an emergency department setting.

1Treatment groups

Experimental Treatment

Group I: Intervention Arm - testingExperimental Treatment1 Intervention

Participants in this arm will be provided the opportunity to self- sample for HPV during their ED visit. Participants will be (1) briefly instructed by the study staff on how to self-sample using a defined instructional script written at an elementary reading level, (2) provided with a packaged swab and vial of transport media, and (3) invited to self- sample privately in their ED room or in one of the private ED restrooms.